Tyra Biosciences (TYRA) Depreciation and Depletion (2020 - 2025)
Tyra Biosciences (TYRA) posted Depreciation and Depletion of $100000.0 for Q1 2025, little changed on a QoQ basis from $100000.0 in Q4 2024, and little changed year-over-year from $100000.0 in Q1 2024.
Tyra Biosciences (TYRA) Depreciation and Depletion (2020 - 2025) Analysis & Trends
Tyra Biosciences' Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $100000.0 for Q1 2025.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $100000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $400000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $500000.0, up 25.0% from the prior year.
- Depreciation and Depletion was $100000.0 for Q1 2025 at Tyra Biosciences, roughly flat from $100000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $41.0 million in Q3 2021 and bottomed at -$89.9 million in Q4 2021.
- A 5-year average of $23764.7 and a median of $100000.0 in 2022 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 156.25% in 2021, while the deepest fall reached 221.47% in 2021.
- Tyra Biosciences' Depreciation and Depletion stood at -$89.9 million in 2021, then jumped by 100.11% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Business Quant data shows TYRA's Depreciation and Depletion at $100000.0 in Q1 2025, $100000.0 in Q4 2024, and $100000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |